Topics and Expertise: type 1 diabetes

Novel diabetes treatment developed in Desai Lab to power SF-area startup

Thu Oct 19, 2017
device alongside a quarter to show size
Encellin

The cell encapsulation device (right) that is being developed by Encellin, a San Francisco–based biotechnology company.

A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.

Roy receives JDRF funding to develop implants to treat type 1 diabetes

Tue Sep 1, 2015
silicon nanopore membranes
© majedphoto.com

Silicon nanopore membranes developed in the Roy Lab will provide material to encapsulate pancreatic islets.

UCSF School of Pharmacy faculty member Shuvo Roy, PhD, has received a three-year $1 million grant to create surgically implantable capsules of donor pancreas cells to free type 1 diabetes patients from daily insulin injections and the disease’s potentially life-threatening complications.